PeopleBeatingCancer

Cardiovascular Disease in Cervical Cancer Survivors

Share Button

How can you manage cardiovascular disease in cervical cancer survivors? By living a heart-healthy lifestyle through nutrition, supplementation, and lifestyle therapies.

There is growing research showing that cervical cancer survivors experience higher rates of cardiovascular disease (CVD) than people without a cancer history.

The research below indicates that cervical cancer survivors — like other cancer survivors — have a significantly higher risk of cardiovascular disease than people without a cancer history. This increased risk persists long after cancer treatment and involves multiple cardiovascular outcomes, including CHD, stroke, and heart failure.

Shared risk factors, treatment-related cardiotoxicity, and cancer-related biological changes all appear to play roles. These findings underscore the importance of integrated survivorship care that addresses heart health alongside cancer monitoring.

I have posted the video below because it explains the problem of cardiovascular disease in cancer survivors, and it explains what to do about it. 

Cardiovascular Disease in the Modern Cancer Survivor

I am a long-term cancer survivor of an incurable blood cancer called multiple myeloma. I was diagnosed with chemotherapy-induced cardiomyopathy in late 2015, fully 15 years after my oncologist prescribed cardiotoxic chemotherapy to me.

The cardio-oncologist prescribed a common heart medication called metoprolol. I think cervical cancer survivors may benefit from conventional heart therapies. My purpose in writing this post is not to condemn conventional heart therapy but rather to promote heart-healthy nutrition, supplementation, and lifestyle.

However, I reacted to the medication and discontinued taking it. I researched evidence-based, heart-healthy therapies that I could pursue on my own, such as exercise, CoQ10, curcumin, omega-3 fatty acids, and cocoa, etc.

Annual echocardiograms over the years have indicated the other heart damage issues below.

I was able to lower my blood pressure, increase my ejection fraction, and stabilize my heart health. I have been able to live without conventional heart medication since 2015.

Again, conventional cardiology should be a part of your long-term survivor plan. I am just saying that evidence-based non-conventional heart health should be included too. Take a multifaceted, complementary approach to supporting your heart.

Scroll down the page, post a question or a comment if you’d like to learn more about non-conventional heart health therapies.

Good luck,

David Emerson

  • Cancer Survivor
  • Cancer Coach
  • Director PeopleBeatingCancer

Unrecognized cardiovascular risks in young cervical cancer patients. Findings from the Rebuc study

Abstract

Background

In recent decades, numerous cohorts have been established to investigate cardiovascular disease (CVD) and mortality among young cancer patients.(1,2) However, these cohorts rarely include young females with cervical cancer, a disease often treated surgically and associated with human papillomavirus (HPV) infection. HPV infections, which can be prevented through vaccination, has also been associated to an elevated risk of CVD. (3)

Purpose

The aim was to study CVD and mortality in young cervical cancer patients.

Method

Using the Rebuc study, which includes all young (<25 years) cancer patients in Sweden from 1958 to 2021. 30,507 individuals aged 15-24 years with cervical cancer (ICD-10 C53) were identified and compared to 152,276 matched controls with regard to CVD (ICD-10 I00–I99 and G45), all-cause mortality, and CV mortality.

Results

The median age at cervical cancer diagnosis was 23 years (IQR 22-24) and the median age at the study’s end was 41 years in both groups (IQR 29-59 vs. 29-60).

CVDs were identified in 5,460 cervical cancer patients (17.9%) and 24,113 controls (15.8%), (Odds ratio (OR) 1.16 95% CI 1.12-1.20 p<0.0001). The risk for ischemic heart disease was 42% higher in cervical cancer patients (OR 95%CI 1.31-1.54, p<0.0001), 54% higher for myocardial infarction (OR 95%CI 1.38-1.72 p<0.0001), 35% higher for heart failure (OR 95% CI1.38-1.72 p<0.0001), and 38% higher risk for cerebrovascular diseases (OR 95%CI 1.26-1.50 p<0.0001) compared to controls.

The risk for all-cause mortality was 64% higher, and the risk for cardiovascular death was 49% higher among females with cervical cancer compared to controls. (Hazard Ratio 95%CI 1.52-1.76; and 1.29-1.70 p <0.0001). Myocardial infarction, sudden cardiac death, and heart failure was the most common cardiovascular causes of death in these young females.

Conclusion

Young females with cervical cancer are at a higher risk of severe CVD and mortality compared to controls. These findings highlight the importance of cardiovascular risk evaluation in cancer patients and contribute to the growing evidence supporting a broad implementation of HPV vaccination programs to reduce the burden of HPV-related diseases.

cardiovascular disease in cervical cancer survivors cardiovascular disease in cervical cancer survivors

 

 

Leave a Comment:

Popular posts

Multiple Myeloma Diet
 Multiple Myeloma Multiple Myeloma Diet
Feb 15, 2022
Multiple Myeloma Survivor- A Different kind of Second Opinion-
 Multiple Myeloma
Nov 04, 2022
C-B-D Enhances Velcade (BORT)
 integrative therapy Multiple Myeloma
Aug 07, 2022
Are Endometrial Polyps Overtreated?
 pre-cancer
Nov 14, 2021